Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of learning phase on complications and oncological quality in robotic left-sided pancreatectomy: A multicenter international analysis.

Surgery·2026
Same author

Comparative Outcomes of Total Versus Partial Pericardiectomy in Constrictive Pericarditis: A Two-Decade Single-Centre Experience.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

CytoSorb® haemoadsorption in high-risk cardiac surgery: A focused review with proposed tiered patient selection.

Perfusion·2026
Same author

Predictors of achieving a textbook outcome following robotic left-sided pancreatectomy: multicentre analysis.

BJS open·2026
Same author

Autoimmune-associated early double bioprosthetic valve failure: A case report.

Perfusion·2025
Same author

Clinical impact of surgical left atrial appendage occlusion during cardiac surgery in patients in sinus rhythm: A meta-analysis.

Heart rhythm·2025
Same journal

The Finding of Posterior Wall Low-Voltage Zones During Cryoballoon Pulmonary Vein Isolation Facilitated by Periprocedural Electroanatomical Mapping Is Associated with a Worse Ablation Outcome.

Journal of cardiovascular development and disease·2026
Same journal

Autonomic Nervous Dysfunction and Ultra-Short-Term Heart Rate Variability in Atrial Fibrillation: Recent Advances in Early Detection.

Journal of cardiovascular development and disease·2026
Same journal

QRS-Corrected Prediction of the Diastolic Rest Period for Coronary CT Angiography in Patients with Complete Left Bundle Branch Block.

Journal of cardiovascular development and disease·2026
Same journal

Colchicine in Coronary Artery Disease-Too Much of a Good Thing?

Journal of cardiovascular development and disease·2026
Same journal

ANO1 (TMEM16A) Genetic Variants, Promoter Methylation, and Chloride Dysregulation in Pulmonary Hypertension.

Journal of cardiovascular development and disease·2026
Same journal

Prognostic Value of the Uric Acid-to-Albumin Ratio in Patients Undergoing Successful Percutaneous Coronary Intervention for Chronic Total Occlusion.

Journal of cardiovascular development and disease·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Carcinoid Heart Disease: Surgical Timing, Right Ventricular Risk Stratification and Operative Strategy.

Hani Ali-Ghosh1, Jason Kho1, Fotios Leventis1

  • 1Department of Cardiac Surgery, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK.

Journal of Cardiovascular Development and Disease
|June 25, 2026
PubMed
Summary
This summary is machine-generated.

Carcinoid heart disease management requires timely surgical intervention, prioritizing right ventricular function. Early detection and multidisciplinary care improve outcomes for patients with neuroendocrine tumors.

Keywords:
carcinoid heart diseasecarcinoid syndromeneuroendocrine tumourpulmonary valve replacementright ventricular functionsurgical timingtricuspid valve replacement

More Related Videos

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

Related Experiment Videos

Last Updated: Jun 26, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

Area of Science:

  • Cardiology
  • Oncology
  • Cardiac Surgery

Background:

  • Carcinoid heart disease (CHD) is a right-sided valvulopathy linked to metastatic neuroendocrine tumors (NETs).
  • Improved NET survival due to oncological therapies shifts mortality focus to cardiac complications.
  • Advanced cardiac dysfunction may be present before symptoms arise, necessitating proactive monitoring.

Purpose of the Study:

  • To review current evidence on surgical timing and strategy for carcinoid heart disease.
  • To discuss prosthesis selection, perioperative management, and novel transcatheter approaches.
  • To emphasize the importance of multidisciplinary decision-making in optimizing patient outcomes.

Main Methods:

  • Synthesis of evidence regarding surgical timing and operative strategy for CHD.
  • Review of prosthesis selection, focusing on bioprosthetic valves.
  • Examination of perioperative endocrine management, including octreotide use.
  • Assessment of emerging transcatheter options for valvular intervention.

Main Results:

  • Tricuspid valve replacement is frequently necessary, often with concomitant pulmonary valve replacement.
  • Bioprosthetic valves are the preferred choice for valve replacement in CHD.
  • Continuous octreotide infusion significantly reduces carcinoid crisis incidence.
  • Preoperative right ventricular function is the key predictor of operative success.

Conclusions:

  • Appropriate surgical timing, guided by multidisciplinary assessment, is crucial for long-term survival.
  • Structured surveillance integrating echocardiography, biomarkers, and oncological status is essential.
  • While surgical outcomes improve, tumor biology remains a critical factor in long-term prognosis.